Sentinel Node Localization and Staging With Low Dose Superparamagnetic Iron Oxide
Status:
Active, not recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
Sentinel lymph node (SLN) status is pivotal for treatment decisions in breast cancer
patients. The dual technique with Technetium99m (Tc99) and blue dye (BD) is yet the current
routine for SLN detection. However, the same reliability has been presented by
superparamagnetic iron oxide nanoparticles (SPIO). The aim of this study was to determine if
SLN detection using ultra-low dose SPIO is feasible.